跳至主要内容
临床试验/ACTRN12612000095864
ACTRN12612000095864尚未招募1 期

combined Use of Oxytocin and Misoprostol versus oxytocin infusion and Misoprostol alone toreduce blood loss at cesarean section

Qazvin University of Medical Science0 个研究点目标入组 150 人开始时间: 2012年1月19日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 42 Years(—)
性别
Female

入选标准

  • pregnant women at term (37—40 wks) gestation scheduled for either elective or emergency lower segment cesarean

排除标准

  • excluding criteria:Women with any risk factor
  • associated with an increased risk of postpartum
  • hemorrhage were excluded i.e. anemia (Hb8 g%), multiple gestation, antepartum hemorrhage,poly-hydramnios, two or more previous cesarean sections and/or a history of previous rupture uterus, current or previous history of significant disease including heart disease, liver, renal disorders or known coagulopathy

研究者

发起方
Qazvin University of Medical Science

相似试验